MYCN and neuroblastoma: ONC201 and ONC206 showed potent activity against the MYCN-amplified IMR-32 and non-MYCN-amplified SK-N-SH human neuroblastoma cell lines via a novel mechanism (inhibition of EGF-induced L1CAM and PDGFRb phosphorylation) [148].